Skip to content
Search

Latest Stories

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

national prescribing service for pharmacists

Sadik Al-Hassan MP

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.


“If a community pharmacy sees an error on a prescription, they will have to phone up the prescriber and ask for a new prescription even though the pharmacist already knows what is wrong and what should be right - this leads to the question of the natural boundary of the profession,” said Hassan.

“The delivery of a national pharmacy-based prescribing service, I believe is entirely possible, I believe it's deliverable, but I believe it's limited now by what we do currently and it shouldn't be.”

As a pharmacist himself, Hassan is aware that community pharmacies have the capability to play integral role in primary care.

“A pharmacy prescribing service could include prescribing decisions based on somebody's genome. The tech isn't that far away,” he said.

“We could actually have testing and understanding of pharmacogenomics, which means prescribing based on somebody's genetic profile.

“We will know which blood pressure medication is actually better than just knowing that your characteristics say a certain medicine will be best in that situation.”

Hassan urged pharmacies to embrace services rather than continuing to spend the majority of their time checking prescriptions and dispensing medicine.

With a team that’s often made up pharmacists, advanced clinical pharmacist, pharmacy technicians, and trainees/apprentices, Hassan believes community pharmacies have a duty to utilise the expertise and upskill their workforce.

“We need to seize the opportunity of the work that's available to us, that's sitting in backlogs of secondary care, that's sitting in new services, that's sitting in new ways to help patients,” he said.

“But all the while we need to have our eye on where pharmacy sits as a profession. Where are our professional boundaries? Where do we add value? And we have to be careful that isn't in the gaps of other people's professions, where we spread ourselves a little too thin.”

Santosh Sahu

Santosh Sahu, founder and CEO of Charac: The Pharmacy App, told attendees that an adequality funded community pharmacy sector had the capability to take the pressure of GPs.

“There are about 350 to 400 million appointments in the primary care network, 80 million of these appointments are about, ‘I don't know what's wrong with me’ (minor ailments),” he said.

“Imagine there is adequate funding and the right technology pathways between the primary care and pharmacies, 80 million of these appointments can be directed to the community pharmacy and it can release time in the GP surgeries where they can attend to people who most require their attention.”

Sahu added: “Pharmacists need technology to free their time so that they can get their head up and think like a business person to do other services. Is government and NHS doing enough for them to do this?”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less